Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target

...nd has issued a $3.57 price target on Inovio Biomedical Corporation (Amex: ino ). "The proposed merger of Inovio and VGX would create a comprehensive DNA ...ap.com . About Inovio Biomedical Corporation: Inovio Biomedical (Amex: ino ) is focused on developing multiple DNA-based immunotherapies. Inovio is a ...

Atom Medical Adopts Masimo Rainbow SET Technology

...emia. According to the American Academy of Pediatrics, "infants who receive ino therapy should be monitored according to institutionally derived protocols designed to avoid the potential toxic effects associated with ino administration. These effects include methemoglobinemia (secondary to exces...

Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target

...nd has issued a $3.52 price target on Inovio Biomedical Corporation (Amex: ino ). "Inovio has compelling pre-clinical and clinical data regarding the abil...tap.com . About Inovio Biomedical Corporation: Inovio Biomedical (AMEX: ino ) is focused on developing multiple DNA-based immunotherapies. Inovio is a ...

Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.

...has nearly 35 years of broad and global experience in the pharmaceutical industry and most recently served as President and Chief Executive Officer of ino Therapeutics LLC., a specialty pharmaceutical company with strengths in development, marketing, and sales of critical care drugs and drug/device combi...

Basic Scientist Mark Roth Wins MacArthur Fellowship

...s work forward into the clinical setting, Roth in 2005 founded a Seattle biotechnology company called Ikaria Inc., which earlier this year merged with ino Therapeutics to become Ikaria Holdings, a leader in the development of therapeutic gases for use in critical-care medicine. The company, based in Clin...

Hiring in the name of talent

...Case as your risk manager, Luke Over as your report editor, and Minnie Mumwage as your compensation analyst. But you may want to take a pass on Howard ino as your research manager and Lou Pole as your tax adviser. Know someone with an interesting job-related name? We'd love to hear it! E-mail Tony a...

More>>